Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SHANGHAI-HENLIUS-BIOTECH--103501663/actualite/Shanghai-Henlius-Biotech-Inc-annonce-l-approbation-de-l-essai-clinique-de-phase-1-de-HLX42-pour-in-45173742/?utm_source=whatsapp&utm_medium=social&utm_campaign=share